Home Top Movers That's how 9 Meters Biopharma (NMTR) stock staying above the limits

That’s how 9 Meters Biopharma (NMTR) stock staying above the limits

A biotechnology firm, 9 Meters Biopharma (NMTR), focuses on patients with rare diseases and unmet needs. The company’s portfolio contains drug candidates with short bowel syndrome (SBS) and celiac disease.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Recent Scores


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


The Company with a Market Cap of 217.64 M was up 27.53% to 1.0700 at yesterday’s close. It stayed up even expanded 23.36% to 1.32 in the extended session. During the last 52-weeks’ time,the Company stock price ranged from $0.3700 to $1.2200. In the previous trading session,17,412,006 shares of NMTR changed hands compared to its average volume of 3,740,066.

Latest Updates

There is no update available or revealed by the company itself in the last 24 hours. However, developments in the previous couple of months have put the stock in positive territory.

• On December 21, 2020, an agreement was revealed between the 9 Meters Biopharma and the European Biomedical Research Institute of Salerno (EBRIS), led to the advancement of a study on larazotide injections in healthy volunteers to evaluate larazotide safety and tolerability in lung tissue.

• On December 16, 2020, the company announced the closing of its previously announced underwritten public offering of 53,076,924 shares of its common stock at a price to the public of $0.65.

• On December 9, 2020,NMTR said that a proprietary long-acting agonist of the GLP-2 receptor had been granted orphan drug designation by the Food and Drug Administration (FDA) as a preventative of acute graft versus host disease.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

SPX Flow Inc. (FLOW) stock surged during current market. Here’s why the stock is sky-rocketing?

SPX Flow Inc. (NASDAQ: FLOW) stock gained by 24.24% in the current market trading session. SPX FLOW, based in Charlotte, works to make the...

Platinum Group Metal Ltd. (PLG) stock surges during after-market trading. Here’s to know what’s happening?

Platinum Group Metal Ltd. (NASDAQ: PLG) stock declined by 8.54% at last close whereas the PLG stock price gains by 7% in the after-market...

17 Education & Technology Group Inc. (YQ) stock plummeting continues on Monday pre-market but why?

17 Education & Technology Group Inc. (YQ) stock has declined 21.28% as of this writing in Monday,s pre-market. In the regular trading session on...

Why did Protagenic Therapeutics Inc. (PTIX) stock commence the new week with a negative trend?

Protagenic Therapeutics Inc. (PTIX) shares declined 13.82% in the pre-market on Monday, July 26, 2021, as of this writing. In after-hours on Friday, Protagenic...

Acorda Therapeutics Inc. (ACOR) stock plunged during pre-market. Here’s what you should know.

Acorda Therapeutics Inc. (ACOR) stock rose by 24.15% at the last close whereas the ACOR stock price fell by 9.30% in the pre-market trading...

Related News

Why did Protagenic Therapeutics Inc. (PTIX) stock commence the new week with a negative trend?

Protagenic Therapeutics Inc. (PTIX) shares declined 13.82% in the pre-market on Monday, July 26, 2021, as of this writing. In after-hours on Friday, Protagenic...

Why Socket Mobile Inc. (SCKT) stock price faced negativity in the pre-market?

Socket Mobile Inc. (SCKT) shares declined 10.18% in pre-hours to $7.50 per share. On Friday, SCKT's stock gained 43.97% to close Friday's morning session...

Veoneer Inc. (VNE) stock shows massive gains during pre-market. What’s driving it high?

Veoneer Inc. (NASDAQ: VNE) stock decline by 1.82% at the last close whereas the VNE stock price gains by 55.19% in the pre-market trading...

AnPac Bio-Medical Sciences Inc. (ANPC) stock soars during pre-market. Here’s what you should know?

AnPac Bio-Medical Sciences Inc. (NASDAQ: ANPC) stock declined by 4.98% at last close however the ANPC stock price gains by 6.96% in the pre-market...

Endeavour Silver Corp. (EXK) stock surged during pre-market trading. Here’s what you should know?

Endeavour Silver Corp. (NASDAQ: EXK) stock declined by 4.97% at the last close whereas the EXK stock price gains by 3.56% in the pre-market...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam